Abstract
The prevalence of obesity has dramatically increased over the past decade along with the cardiovascular and other health risks it encompasses. Adipose tissue, which is distributed in the abdominal viscera, carries a greater risk for cardiovascular disorders than adipose tissue subcutaneously. There is a sex difference in the regional fat distribution. Women have more subcutaneous fat, whereas men have more visceral fat. Therefore, obesity-related metabolic disorders are much lower in premenopausal women than men. Peripheral metabolic signals like leptin and insulin are involved in the food intake, body weight, body fat distribution, and cardiovascular disease. Key areas in the brain, including the hypothalamus, integrates these peripheral adiposity signals to maintain overall adiposity levels, and these brain regions are directly influenced by sex hormones. Therefore, differences in cardiovascular disease may be under the influence of sex hormones either directly in the brain or through their influence of body fat distribution. The role of estrogen in mediating body fat distribution and cardiovascular disease is the focus of this review.
Similar content being viewed by others
References
Ahima, R. S., Kelly, J., Elmquist, J. K., & Flier, J. S. (1999). Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology, 140(11), 4923–4931.
Ainslie, D. A., Morris, M. J., Wittert, G., Turnbull, H., Proietto, J., & Thorburn, A. W. (2001). Estrogen Deficiency Causes Central Leptin Insensitivity and Increased Hypothalamic Neuropeptide Y. International Journal of Obesity and Related Metabolic Disorders, 25(11), 1680–1688.
Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P. (2002). Sympathetic neural activation in visceral obesity. Circulation, 106(20), 2533–2536.
Baltatzi, M., Hatzitolios, A., Tziomalos, K., Iliadis, F., & Zamboulis, C. H. (2008). Neuropeptide Y and alpha-melanocyte-stimulating hormone: Interaction in obesity and possible role in the development of hypertension. International Journal of Clinical Practice, 62(9), 1432–1440.
Barzilai, N., Wang, J., Massilon, D., Vuguin, P., Hawkins, M., & Rossetti, L. (1997). Leptin selectively decreases visceral adiposity and enhances insulin action. Journal of Clinical Investigation, 100(12), 3105–3110.
Bates, S. H., Stearns, W. H., Dundon, T. A., Schubert, M., Tso, A. W., Wang, Y., et al. (2003). STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature, 421, 856–859.
Bays, H. E. (2009). Sick fat, metabolic disease, and atherosclerosis. American Journal of Medicine, 122(1 Suppl), S26–S37.
Bennett, P. A., Lindell, K., Wilson, C., Carlsson, L. M., Carlsson, B., & Robinson, I. C. (1999). Cyclica variations in the abundance of leptin receptors, but not in circulating leptin, correlate with NPY expression during the oestrous cycle. Neuroendocrinology, 69(6), 417–423.
Berthoud, H. R., & Morrison, C. (2008). The brain, appetite, and obesity. Annual Review of Psychology, 59, 55–92.
Bjorntorp, P. (1992). Abdominal fat distribution and disease: An overview of epidemiological data. Annals of Medicine, 24(1), 15–18.
Bjorntorp, P. (1992). Abdominal fat distribution and the metabolic syndrome. Journal of Cardiovascular Pharmacology, 20(Suppl 8), S26–S28.
Bjorntorp, P. (1996). The android woman—a risky condition. Journal of Internal Medicine, 239(2), 105–110.
Bjorntorp, P. (1997). Hormonal control of regional fat distribution. Human Reproduction, 12(Suppl 1), 21–25.
Bruning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., et al. (2000). Role of brain insulin receptor in control of body weight and reproduction. Science, 289(5487), 2122–2125.
Clegg, D. J., Brown, L. M., Woods, S. C., & Benoit, S. C. (2006). Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes, 55(4), 978–987.
Clegg, D. J., Riedy, C. A., Smith, K. A., Benoit, S. C., & Woods, S. C. (2003). Differential sensitivity to central leptin and insulin in male and female rats. Diabetes, 52(3), 682–687.
Colombel, A., & Charbonnel, B. (1997). Weight gain and cardiovascular risk factors in the post-menopausal women. Human Reproduction, 12(Suppl 1), 134–145.
Coppack, S. W. (2005). Adipose tissue changes in obesity. Biochemical Society Transactions, 33(Pt 5), 1049–1052.
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., et al. (2001). Leptin activates anorexigenic pomc neurons through a neural network in the arcuate nucleus. Nature, 411(6836), 480–484.
Cummings, D. E., & Schwartz, M. W. (2003). Genetics and pathophysiology of human obesity. Annual Review of Medicine, 54, 453–471.
de Wardener, H. E. (2001). The hypothalamus and hypertension. Physiological Reviews, 81(4), 1599–1658.
Demerath, E. W., Towne, B., Wisemandle, W., Blangero, J., Chumlea, W. C., & Siervogel, R. M. (1999). Serum leptin concentration, body composition, and gonadal hormones during puberty. International Journal of Obesity and Related Metabolic Disorders, 23(7), 678–685.
Despres, J. P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., et al. (2008). Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(6), 1039–1049.
Eckel, R. H., Barouch, W. W., & Ershow, A. G. (2002). Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation, 105(24), 2923–2928.
Flegal, K. M., Carroll, M. D., Ogden, C. L., & Johnson, C. L. (2002). Prevalence and trends in obesity among Us Adults, 1999–2000. Jama, 288(14), 1723–1727.
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome among Us Adults: Findings from the third national health and nutrition examination survey. JAMA, 287(3), 356–359.
Ford, E. S., Li, C., Zhao, G., Pearson, W. S., & Mokdad, A. H. (2008). Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care, 31(3), 587–589.
Frederich, R. C., Hamann, A., Anderson, S., Lollmann, B., Lowell, B. B., & Flier, J. S. (1995). Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Medicine, 1(12), 1311–1314.
Gao, Q., Mezei, G., Nie, Y., Rao, Y., Choi, C. S., Bechmann, I., et al. (2007). Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nature Medicine, 13(1), 89–94.
Hajer, G. R., van Haeften, T. W., & Visseren, F. L. (2008). Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal, 29(24), 2959–2971.
Hall, J. E., Hildebrandt, D. A., & Kuo, J. (2001). Obesity hypertension: Role of leptin and sympathetic nervous system. American Journal of Hypertension, 14(6 Pt 2), 103S–115S.
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000). Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 97(23), 12729–12734.
Keesey, R. E., & Powley, T. L. (1986). The regulation of body weight. Annual Review of Psychology, 37, 109–133.
Kotani, K., Tokunaga, K., Fujioka, S., Kobatake, T., Keno, Y., Yoshida, S., et al. (1994). Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. International Journal of Obesity and Related Metabolic Disorders, 18(4), 207–2.
Lafontan, M., & Berlan, M. (1995). Fat cell alpha 2-adrenoceptors: The regulation of fat cell function and lipolysis. Endocrine Reviews, 16(6), 716–738.
Lamarche, B. (1998). Abdominal obesity and its metabolic complications: Implications for the risk of ischaemic heart disease. Coronary Artery Disease, 9(8), 473–481.
Llado, I., Rodriguez-Cuenca, S., Pujol, E., Monjo, M., Estrany, M. E., Roca, P., et al. (2002). Gender effects on adrenergic receptor expression and lipolysis in white adipose tissue of rats. Obesity Research, 10(4), 296–305.
McEwen, B. S. (1999). Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system. Journal of Clinical Endocrinology and Metabolism, 84(6), 1790–1797.
McEwen, B. S., & Alves, S. E. (1999). Estrogen actions in the central nervous system. Endocrine Reviews, 20(3), 279–307.
Mendelsohn, M. E., & Karas, R. H. (1999). The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine, 340(23), 1801–1811.
Musatov, S., Chen, W., Pfaff, D. W., Mobbs, C. V., Yang, X. J., Clegg, D. J., et al. (2007). Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 104(7), 2501–2506.
O'Dea, J. A. (2008). Gender, ethnicity, culture and social class influences on childhood obesity among Australian schoolchildren: Implications for treatment, prevention and community education. Health & Social Care in the Community, 16(3), 282–290.
Ohlsson, C., Hellberg, N., Parini, P., Vidal, O., Bohlooly, Y. M., Rudling, M., et al. (2000). Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochemical and Biophysical Research Communications, 278(3), 640–645.
Popkin, B. M., & Doak, C. M. (1998). The obesity epidemic is a worldwide phenomenon. Nutrition Reviews, 56(4 Pt 1), 106–114.
Rebuffe-Scrive, M., Andersson, B., Olbe, L., & Bjorntorp, P. (1989). Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism, 38(5), 453–458.
Rebuffe-Scrive, M., Enk, L., Crona, N., Lonnroth, P., Abrahamsson, L., Smith, U., et al. (1985). Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. Journal of Clinical Investigation, 75(6), 1973–1976.
Sainsbury, A., Cooney, G. J., & Herzog, H. (2002). Hypothalamic regulation of energy homeostasis. Best Practice and Research Clinical Endocrinology and Metabolism, 16(4), 623–637.
Schomberg, D. W., Couse, J. F., Mukherjee, A., Lubahn, D. B., Sar, M., Mayo, K. E., et al. (1999). Targeted disruption of the estrogen receptor-alpha gene in female mice: Characterization of ovarian responses and phenotype in the adult. Endocrinology, 140(6), 2733–2744.
Schwartz, M. W., Woods, S. C., Porte, D., Jr., Seeley, R. J., & Baskin, D. G. (2000). Central nervous system control of food intake. Nature, 404(6778), 661–671.
Shi, H., & D. J. Clegg (2009) Sex differences in the regulation of body weight. Physiology and Behavior. doi:10.1016/jphysbeh.2009.02.017.
Shi, H., Strader, A. D., Sorrell, J. E., Chambers, J. B., Woods, S. C., & Seeley, R. J. (2008). Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis. The American Journal of Physiology—Endocrinology and Metabolism, 294(3), E630–E639.
Simpson, E. R., & Jones, M. E. (2006). Of mice and men: The many guises of estrogens. Ernst Schering Foundation Symposium Proceedings, 1, 45–67.
Syme, C., Abrahamowicz, M., Leonard, G. T., Perron, M., Pitiot, A., Qiu, X., et al. (2008). Intra-abdominal adiposity and individual components of the metabolic syndrome in adolescence: Sex differences and underlying mechanisms. Archives of Pediatrics and Adolescent Medicine, 162(5), 453–461.
Tchoukalova, Y. D., Koutsari, C., Karpyak, M. V., Votruba, S. B., Wendland, E., & Jensen, M. D. (2008). Subcutaneous adipocyte size and body fat distribution. American Journal of Clinical Nutrition, 87(1), 56–63.
Thammacharoen, S., Lutz, T. A., Geary, N., & Asarian, L. (2008). Hindbrain administration of estradiol inhibits feeding and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats. Endocrinology, 149(4), 1609–1617.
Vague, J. (1947). La differe´nciation sexuelle, facteur determinant des formes de l'obe´site. Presse me´d, 55, 339–340.
Wajchenberg, B. L. (2000). Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocrine Reviews, 21(6), 697–738.
Woods, S. C., & Seeley, R. J. (2001). Insulin as an adiposity signal. International Journal of Obesity and Related Metabolic Disorders, 25(Suppl 5), S35–S38.
Woods, S. C., Seeley, R. J., Porte, D., Jr., & Schwartz, M. W. (1998). Signals that regulate food intake and energy homeostasis. Science, 280(5368), 1378–1383.
Yu, I. C., Lin, H.-Y., Liu, N.-C., Wang, R.-S., Sparks, J. D., Yeh, S., et al. (2008). Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology, 149, 2361–2368.
Hallschmid, M., Benedict, C., Schultes, B., Fehm, M.-L., Born, J., & Kern, W. (2004). Intranasal insulin reduces body fat in men but not in women. Diabetes, 53, 3024–3029.
Titolo, D., Cai, F., & Belsham, D. D. (2006). Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER)alpha to ERbeta in colonal hypothalamic neurons. Molecular Endocrinology, 20(9), 2080–2092.
Egan, K. M., Lawson, J. A., Fries, S., Koller, B., Rader, D. J., Smyth, E. M., et al. (2004). Cox-2-derived prostacyclin confers atheroprotection on female mice. Science, 306(5703), 1954–1957.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nedungadi, T.P., Clegg, D.J. Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases. J. of Cardiovasc. Trans. Res. 2, 321–327 (2009). https://doi.org/10.1007/s12265-009-9101-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-009-9101-1